New treatments evaluation

 

While ITV-1 is Immunotech’s flagship compound for the treatment of HIV/AIDS and Hepatitis C, other compounds in Immunotech’s pipeline are also in development for the treatment HIV/AIDS.

pipelineImmunotech’s commitment to the treatment and eradication of HIV extends not only to adult HIV/AIDS patients, but also for Prenatal and Pediatric HIV, as well as the development of an HIV Vaccine.